Jpmorgan Chase & Co »

Cardiol Therapeutics Inc- foreign shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Cardiol Therapeutics Inc- foreign (CRDL) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Cardiol Therapeutics Inc- foreign

Tip: Access up to 7 years of quarterly data

All positions including Cardiol Therapeutics Inc- foreign held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cardiol Therapeutics Inc- foreign by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $50k 48k 1.03
2026-03-31 $59k 48k 1.22
2024-09-30 $5.0k 2.5k 1.98

More positions owned by Jpmorgan Chase & Co

Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Microsoft Corp Common (MSFT)
Alphabet Common (GOOG)
Amazon Common (AMZN)
Broadcom Common (AVGO)
State Street Spdr S&p 500 Etf Fund (SPY)
Alphabet Common (GOOGL)
Micron Technology Common (MU)
Meta Platforms Common (META)
Advanced Micro Devices Common (AMD)
Lam Research Corp Common (LRCX)
Tesla Common (TSLA)
Vanguard S&p 500 Etf Fund (VOO)
Eli Lilly & Co Common (LLY)

View all positions for Jpmorgan Chase & Co

Top funds holding Cardiol Therapeutics Inc- foreign

MMCAP International Inc. SPC
Tejara Capital
Ikarian Capital
Boothbay Fund Management
Citadel Advisors
Renaissance Technologies
Two Sigma Investments
Integrity Alliance
Goldman Sachs Group
Morgan Stanley
Pvg Asset Management
We Are One Seven
Goodman & Company, Investment Counsel
Summit Financial
Jane Street

View all funds holding Cardiol Therapeutics Inc- foreign